NCT05921786 Record Voxel Rate Nonlinear Optical Microscope to Unravel Brain Connectome and Signaling-Establish Reliably Electrophysiological Readouts From Human-induced Pluripotent Stem Cells (hiPSCs)-Derived Cerebral Organoids and Surgically Dissected Human Live Brains
| NCT ID | NCT05921786 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital |
| Condition | Brain Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 500 participants |
| Start Date | 2023-05-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 500 participants in total. It began in 2023-05-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The research aims to establish a big database of multiple kinds of brain tissues and prove the relevance of human brain tissue models and hiPSCs-derived organoid models.
Eligibility Criteria
Inclusion Criteria: 1\. Patients older than the age of 18 with diagnosis of brain disease (both newly-diagnosed or recurrent) who are suitable and willing to receive resection surgery. Exclusion Criteria: 1. Patients who cannot give consent to participate in the study. 2. The tumor samples failed to give a conclusive pathological diagnosis by standard pathological workflow. 3. Patients who only receives biopsy surgery rather than resection surgery. 4. Significant post-irradiation effect or radiation necrosis reported in the pathological examination.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05921786 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Brain Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05921786 currently recruiting?
Yes, NCT05921786 is actively recruiting participants. Contact the research team at wang081466@yahoo.com.tw for enrollment information.
Where is the NCT05921786 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT05921786 clinical trial?
NCT05921786 is sponsored by National Taiwan University Hospital. The trial plans to enroll 500 participants.